title: Aβ immunotherapy for Alzheimer's disease: where are we?
authors.affiliation: Protein Folding & Stability Group, Departament de Bioquímica i Biologia Molecular, Unitat de Biociències, Universitat Autònoma de Barcelona, Campus Bellaterra 08193, Cerdanyola del Vallès, Spain.
authors.forename: Jofre
authors.initials: J
authors.lastname: Güell-Bosch
authors.affiliation: Protein Folding & Stability Group, Departament de Bioquímica i Biologia Molecular, Unitat de Biociències, Universitat Autònoma de Barcelona, Campus Bellaterra 08193, Cerdanyola del Vallès, Spain.
authors.forename: Laia
authors.initials: L
authors.lastname: Montoliu-Gaya
authors.affiliation: Protein Folding & Stability Group, Departament de Bioquímica i Biologia Molecular, Unitat de Biociències, Universitat Autònoma de Barcelona, Campus Bellaterra 08193, Cerdanyola del Vallès, Spain.
authors.forename: Gisela
authors.initials: G
authors.lastname: Esquerda-Canals
authors.affiliation: Protein Folding & Stability Group, Departament de Bioquímica i Biologia Molecular, Unitat de Biociències, Universitat Autònoma de Barcelona, Campus Bellaterra 08193, Cerdanyola del Vallès, Spain.
authors.forename: Sandra
authors.initials: S
authors.lastname: Villegas
mesh_terms: D000544:Alzheimer Disease / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000276:immunology*; D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D007116:Immunization, Passive; D007155:Immunologic Factors / Q000627:therapeutic use; D016233:Immunotherapy, Active
chemical_list: D016229:Amyloid beta-Peptides; D007155:Immunologic Factors
keywords: Alzheimer's disease; amyloid-β; immunotherapy; new therapies; vaccine